Daily adaptive radiotherapy for head and neck cancer to spare salivary glands
Part of Cancer clinical trials.
This trial tests a new daily adaptive radiotherapy technique that aims to spare the submandibular salivary glands during head and neck cancer treatment. It may help reduce dry mouth after radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have squamous cell head and neck cancer confirmed by biopsy
- You are getting radiation to both sides of your neck
- You are able to lie flat on your back for about an hour
- Your general health is good (able to care for yourself)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if using an MRI to map saliva glands before radiation can help spare them, reducing dry mouth. It is for people with oropharynx cancer who will receive radiation with or without chemotherapy.
This trial tests a newer, more precise way of giving daily radiation for head and neck cancer. The treatment plan is adjusted each day to better target the tumor and protect healthy tissue.
This Phase 1 study tests whether transplanting stem cells into the submandibular gland can help restore saliva function after surgery and radiation for oral cavity squamous cell cancer. You may be considered because you recently had tumor removal and radiation aimed at the neck area, which can damage salivary glands.
This Phase 3 study compares a standard radiation approach versus a modified approach designed to spare key swallowing and aspiration (choking) related areas and one salivary gland. It may help reduce treatment side effects that affect swallowing and quality of life for certain head and neck cancer patients.
This trial compares a new radiation technique designed to reduce dry mouth (xerostomia) with standard radiation for people with nasopharyngeal cancer. It aims to see if the new approach can protect saliva glands while still treating the cancer effectively.
This trial tests a new way of giving radiation therapy, called adaptive radiation boost, for people with head and neck cancer. The goal is to see if this approach can better target the cancer and possibly improve outcomes.
Hear when a new Squamous Cell Cancer of Head and Neck (SCCHN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.